Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Why is the UK lagging behind the rest of Europe in cancer survival?

November 5, 2015 | Cancer Research, Cancer Research UK, Healthcare Technology, cancer daignosis, prostate cancer 

Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK

Having to wait for tests, test results, diagnosis and then treatment can be a gruelling experience with the big C word hovering over your head. NHS guidelines are in place to limit diagnosis time but as the Guardian reports, hospitals often break them due to high patient numbers. Cancer survival rates are thankfully rising but the UK has been reported as falling behind the rest of Europe. Why? The main reason cited is slow diagnosis; with the Telegraph stating one in five cancers in this country are not spotted until the patient ends up in A&E.

The best diagnostics we have now are specialised scanners, such as MRI, which are expensive and only found at large hospitals. This bottlenecks patients, delaying diagnosis, and creating postcode variation.

The potential of a simple blood test to save lives

The dream is to find cancers when they’re at their early and most importantly, curable stage. Labs around the world are competing to find a blood test or ‘liquid biopsy’ which can do this, by screening a sample of the patient’s blood. All the DNA in the blood sample is sequenced to find specific shed DNA fragments which are expelled from cancerous cells. You need DNA sequencing machines to do this, but that technology is advancing at an incredible rate, with price and time reducing hugely ever year. A DNA sequencer no bigger than a mobile phone impressed experts earlier this year.

Some studies are being conducted as a race between liquid biopsy and traditional diagnostic tools, such as ultrasound. Catch the cancer. Ready. Steady. Go. Another study found tumour DNA in blood samples of over 80% of those with advanced cancers and nearly 50% with localised and early stage cancers. Research on prostate, lung and bowel cancer tests are under way at the Royal Marsden and a similar blood test has already been reported as a breakthrough for predicting relapses in breast cancer.

To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “stethoscope for the next 200 years.”  A researcher called Dennis Lo, who is close to perfecting the screen for nasopharyngeal cancer, believes once the test has been developed for common cancers, it will be rolled out to mainstream. Victor Velculescu, another pioneer thinks liquid biopsies will “solve early detection” which is key to improving survival rates here in Britain.

I personally, don’t think this technology can come soon enough, just like cancer patients think, waiting for their diagnosis.

-Written by Becky W.

This content was provided by Say Communications

Company Details

- PMLiVE

Say Communications

Email
Website

 Latest Content from  Say Communications 

B2B social media: a spring 2016 review

Is your social media strategy on point? Take a look at the latest trends in B2B social media.

Why everyone is standing-up to the sitting-down problem

Are the exercise gurus really onto something? Find out how workplace fitness can boost your health and reduce your bum, while helping you become more productive throughout the day.

No one needs to go hungry in London

Our Say blogger returns to St James’s Church Winter Shelter for an overnight shift for the West London Day Centre charity.

Should We Care About Rare Diseases? By Alastair Kent

Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Changing faces – overcoming the taboo of marketing to a mature audience

Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.

I want to ride my bicycle, I want to ride my bike!

Our team’s motivations behind cycling on two static bikes for 282 miles - the equivalent of London to Paris, to raise money for British Dupuytren’s Society. Please donate!

Life hacks to stay safe online

Conducting our cyber lives, we easily forget and probably ignore the dangers our careless online behaviour can cause. Our new blog provides advice on personal IT to help you to...

How will child public health be prioritised? by Alison Wall

Public health strategist Alison Wall stresses the importance of child public health as a commissioning responsibility.

Cold weather is yet to start at St James’s Winter Shelter

First shift at the St James’s Church Winter Shelter, cooking dinner for fifteen of London’s homeless, and encourages us all to consider volunteering this winter.